Similar articles

• Summaries for patients. Treating men with chronic prostatitis/chronic pelvic pain syndrome.

  [No authors listed] [No authors listed] Ann Intern Med. 2004 Oct 19;141(8):I8. doi: 10.7326/0003-4819-141-8-200410190-00004. Ann Intern Med. 2004. PMID: 15492335 No abstract available.
• Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial.

  Alexander RB, Propert KJ, Schaeffer AJ, Landis JR, Nickel JC, O'Leary MP, Pontari MA, McNaughton-Collins M, Shoskes DA, Comiter CV, Datta NS, Fowler JE Jr, Nadler RB, Zeitlin SI, Knauss JS, Wang Y, Kusek JW, Nyberg LM Jr, Litwin MS; Chronic Prostatitis Collaborative Research Network. Alexander RB, et al. Ann Intern Med. 2004 Oct 19;141(8):581-9. doi: 10.7326/0003-4819-141-8-200410190-00005. Ann Intern Med. 2004. PMID: 15492337 Clinical Trial.
• Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome.

  Propert KJ, Alexander RB, Nickel JC, Kusek JW, Litwin MS, Landis JR, Nyberg LM, Schaeffer AJ; Chronic Prostatitis Collaborative Research Network. Propert KJ, et al. Urology. 2002 Jun;59(6):870-6. doi: 10.1016/s0090-4295(02)01601-1. Urology. 2002. PMID: 12031372 Clinical Trial.
• Role of alpha1-blockers in chronic prostatitis syndromes.

  Nickel JC. Nickel JC. BJU Int. 2008 Mar;101 Suppl 3:11-6. doi: 10.1111/j.1464-410X.2008.07496.x. BJU Int. 2008. PMID: 18307680 Review.
• The three As of chronic prostatitis therapy: antibiotics, alpha-blockers and anti-inflammatories. What is the evidence?

  Nickel JC. Nickel JC. BJU Int. 2004 Dec;94(9):1230-3. doi: 10.1111/j.1464-410X.2004.05148.x. BJU Int. 2004. PMID: 15610095 Review. No abstract available.